| CXHL2200893 | 莫非赛定利托那韦片 | morphothiadine mesylate;ritonavir | Tablet | Chemical Drugs(1) | New Drug Application | 2022-11-12 | | Sunshine Lake Pharma Co Ltd | | | view |
| JYHB1700866 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2017-06-19 | AbbVie Ltd. | Abbvie Ltd | Filed | 2017-09-12 | view |
| JYHB1201237 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2012-11-08 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2013-07-15 | view |
| JYHB2000638 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
| JYHZ2200202 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2022-07-18 | | | | | view |
| JYHB1601599 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2016-12-06 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2017-07-18 | view |
| JYHS2300030 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-22 | | | | | view |
| JYHB1701091 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2017-08-21 | AbbVie Ltd. | Abbvie Ltd | In Review | 2017-08-19 | view |
| JYHB2001606 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
| JYHB0901041 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2009-12-04 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2010-05-18 | view |
| JYHB2000637 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
| JYHB1900178 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |
| JYHB1601600 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2016-12-06 | AbbVie Ltd. | Abbvie Ltd | Certificate Issued | 2017-05-04 | view |
| JYHZ1700275 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2017-08-21 | AbbVie Ltd. | Abbvie Ltd | Certificate Issued | 2018-03-19 | view |
| JYHB2001605 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
| JYHB1500736 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2015-06-02 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2016-07-18 | view |
| JYHB0800488 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2008-07-24 | Abbott Laboratories Limited | Abbott Laboratories Ltd | Certificate Issued | 2009-03-26 | view |
| JYHB1700865 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2017-06-19 | AbbVie Ltd. | Abbvie Ltd | Filed | 2017-07-17 | view |
| JYHB1401281 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2014-09-17 | AbbVie Ltd, | Abbvie Ltd | Certificate Issued | 2015-01-27 | view |
| JYHB1900177 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |
